ZyVersa Therapeutics CEO Stephen C. Glover as Key Speaker at H.C. Wainwright Kidney Conference
ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited Speaker
Stephen C. Glover, CEO of ZyVersa Therapeutics, is poised to deliver a keynote address at the esteemed H.C. Wainwright 3rd Annual Kidney Conference. The event, scheduled to take place virtually on July 15, 2024, will offer valuable insights into the latest developments in the field of kidney disorders.
H.C. Wainwright 3rd Annual Kidney Conference
Glover's participation at the conference underlines ZyVersa's commitment to driving innovation in the treatment of kidney-related ailments. His presence as a key speaker signifies the company's dedication to advancing the understanding of kidney health and fostering collaborations within the healthcare sector.
- Key Points:
- Glover to deliver keynote address at H.C. Wainwright 3rd Annual Kidney Conference
- Conference scheduled for July 15, 2024, to be held virtually
- ZyVersa Therapeutics' CEO highlighting company's leadership in kidney health
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.